Prevalence of pulmonary disorders in patients with newly diagnosed rheumatoid arthritis.
Our objective was to determine the prevalence of airway hyperreactivity (AHR) in patients with newly diagnosed rheumatoid arthritis (RA) who had received no disease-modifying antirheumatic drugs (DMARDs) and to characterise the spectrum of lung diseases identifiable in these patients at the time of presentation. Eighteen consecutive patients with newly diagnosed RA referred to our medical centre's rheumatology clinic over 2 years underwent pulmonary evaluation with arterial blood gas analysis, chest radiographs, spirometry before and after bronchodilator medication, and body plethysmography. They returned on subsequent days in random order for methacholine inhalation challenge (MIC) and eucapnic voluntary hyperventilation (EVH) as bronchoprovocation techniques. One patient had severe obstructive disease at presentation and therefore did not undergo bronchoprovocation. We found a wide variety of pulmonary abnormalities, including two patients with hypoxia (12%), two with obstruction (12%), three with restriction (18%) and four with AHR (23%). The data also suggest a strong association between pulmonary diseases in RA and cigarette smoking. Although no single characteristic lung disease such as AHR was identified in patients presenting with RA, the association between lung disease and cigarette smoking is striking and underscores the need to emphasise smoking cessation in this patient population.
Doyle
J J
JJ
Department of Medicine, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.
Eliasson
A H
AH
Argyros
G J
GJ
Dennis
G J
GJ
Finger
D R
DR
Hurwitz
K M
KM
Phillips
Y Y
YY
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000150:complications*; D016535:Bronchial Hyperreactivity / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D001985:Bronchial Provocation Tests / Q000379:methods; D016085:Bronchoconstrictor Agents; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D008396:Maryland; D016210:Methacholine Chloride; D008875:Middle Aged; D012907:Smoking / Q000009:adverse effects; D014109:Total Lung Capacity
D016085:Bronchoconstrictor Agents; D016210:Methacholine Chloride